Abstract: Porous polymer particles include a polymer matrix and a pore dispersed in the polymer matrix. The pore has a diameter ranging from 50 nm to 500 nm; An epoxy content contained in 1 g of the porous polymer particles ranges from 500 ?mol to less than 5000 ?mol. Also provided is a column for protein purification including porous polymer particles.

Abstract: A row decoder includes first and second main wordline driving circuits, which are configured to generate respective first and second driving signals onto corresponding first and second main wordlines extending adjacent to each other. In addition, a first transistor within the first main wordline driving circuit and a second transistor within the second main wordline driving circuit have the same function, but extend in different rows when viewed in a direction perpendicular to a substrate on which the first and second main wordlines are formed.

Abstract: The present invention relates to a microcarrier for cell culture comprising: polystyrene-based particles that includes at least one of a hydrocarbon oil having 12 or more carbon atoms, or a void derived therefrom; and magnetic particles.

Abstract: The present disclosure relates to a method for preparing a biodegradable and eco-friendly organic-inorganic hybrid microcapsule having few toxic substances with high versatility and economical efficiency by using a pickering emulsion method with a specific outer wall reinforcing material, a reactive material, and inorganic nanoparticles, and allowing polymerization of the outer wall reinforcing material and the reactive material to proceed at the interface. Specifically, the organic-inorganic hybrid microcapsule can stably support an active ingredient and then effectively express its activity by pressure, and exhibit a characteristic of gradually releasing the active ingredient at room temperature.

Abstract: The present disclosure relates to a microcarrier for cell culture comprising: polystyrene-based particles containing at least one or more of hydrocarbon oil having 12 or more carbon atoms, or pores derived therefrom, a method for producing the same, and a cell culture composition using the same.

Abstract: The present application relates to microcarrier particles for cell culture, a method for preparing the particles, and a cell culture medium composition including the particles. According to the present application, a microcarrier having a high degree of uniformity in shape or form, having porosity, and advantageous for cell attachment and isolation of cultured cells is provided.

Abstract: The present disclosure relates to a method of preparing polymeric microparticles that can realize excellent mechanical strength and stability as well as high crosslinking efficiency and production yield, polymeric microparticles, medical compositions, cosmetic compositions, medical articles and cosmetic articles comprising the same.

Abstract: The present disclosure relates to a microcarrier that has excellent adhesion to cells and also is easily isolated from cells after culturing, a method for producing the same, and a cell culture method using the same.

Abstract: The present disclosure provides a method for preparing a microcapsule and a microcapsule prepared thereby capable of selective release of oils and preventing volatilization of oils while maintaining long-term performance by improving storage stability of the oil contained in the capsule.

Abstract: The present disclosure relates to a method for preparing a biodegradable and eco-friendly organic-inorganic hybrid microcapsule having few toxic substances with high versatility and economical efficiency by using a pickering emulsion method with a specific outer wall reinforcing material, a reactive material, and inorganic nanoparticles, and allowing polymerization of the outer wall reinforcing material and the reactive material to proceed at the interface. Specifically, the organic-inorganic hybrid microcapsule can stably support an active ingredient and then effectively express its activity by pressure, and exhibit a characteristic of gradually releasing the active ingredient at room temperature.

Abstract: The present invention relates to a pharmaceutical combined composition for preventing or treating cancer comprising a compound of formula 1 or a pharmaceutically acceptable salt thereof and topoisomerase inhibitor as active ingredients. The pharmaceutical combined composition of the present invention specifically inhibits cell proliferation and induces apoptosis as to various cancers such as colorectal cancer and ovarian cancer that a vascular disrupting agent cannot treat due to a complex inhibition mechanism of neoplasm of the compound of formula 1 and the pharmaceutically acceptable salt thereof and topoisomerase inhibitor, and thereby it can be usefully used for preventing and treating cancer.

Abstract: The present invention relates to a pharmaceutical combined composition for preventing or treating cancer comprising a compound of formula 1 or a pharmaceutically acceptable salt thereof and topoisomerase inhibitor as active ingredients. The pharmaceutical combined composition of the present invention specifically inhibits cell proliferation and induces apoptosis as to various cancers such as colorectal cancer and ovarian cancer that a vascular disrupting agent cannot treat due to a complex inhibition mechanism of neoplasm of the compound of formula 1 and the pharmaceutically acceptable salt thereof and topoisomerase inhibitor, and thereby it can be usefully used for preventing and treating cancer.